Maternal Vaccination for RSV Cuts Infant RSV Hospitalization Rates

By Debbie Bunch

June 29, 2026 | 2 min read

University of Pittsburgh researchers publishing in JAMA Network Open have found that women who receive the RSV prefusion F (RSVpreF) vaccine while they are pregnant are significant less likely to have a newborn who requires hospitalization for RSV. The vaccine, which protects against RSV-A and RSV-…

This content is for AARC members only.

Become a Member

Read Full Paper Read Article

Debbie Bunch

Debbie Bunch has a bachelor's degree in journalism from the University of North Texas and lives in Dallas, Texas. She has spent many years writing for the AARC on topics ranging from clinical innovations to management. In her spare time, she enjoys traveling, reading, photography, and spending time with friends, family, and her rescue pup Juju.

Share